$SYBX
Synlogic Inc
PRICE
$1.1 -
Extented Hours
VOLUME
98,657
DAY RANGE
1.07 - 1.14
52 WEEK
1.02 - 4.54
Key Metrics
Market Cap
77.28 M
Beta
0.96
Avg. Volume
173.98 K
Shares Outstanding
70.25 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-11
Next Dividend Date
Company Information
Synlogicβ’ is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering, Synlogic designs Synthetic Biotic therapeutics that target validated underlying biology to treat disease in new ways. Synlogic's proprietary pipeline includes Synthetic Biotics for the treatment of metabolic disorders including Phenylketonuria (PKU) and Enteric Hyperoxaluria (HOX). The company is also building a portfolio of partner-able assets in immunology and oncology.
CEO: Aoife Brennan
Website: www.synlogictx.com
HQ: 301 Binney St Ste 402 Cambridge, 02142-1030 Massachusetts
Related News